Eli Lilly | LLY - Trade Creditors

Stock Price
1,047.91
Daily Change
-10.65 -1.01%
Monthly
-1.40%
Yearly
18.89%
Q1 Forecast
978.22

Eli Lilly reported $5.38B in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Abbott USD 4.12B 183M Sep/2025
ALKERMES USD 68M 31.21M Sep/2025
Amgen USD 20.89B 1.25B Dec/2025
AstraZeneca USD 25.28B 252M Dec/2025
Baxter International USD 999M 46M Dec/2025
Biogen USD 432M 18.9M Dec/2025
Bristol-Myers Squibb USD 4.29B 1.14B Sep/2025
Coherus Biosciences USD 24.89M 12.73M Sep/2025
Drreddys Laboratories INR 454.04M 854K Dec/2025
Eli Lilly USD 5.38B 1.12B Dec/2025
Gilead Sciences USD 808M 226M Sep/2025
GlaxoSmithKline GBP 15.38B 294M Dec/2025
Glaxosmithkline GBP 21.07B 7.42B Sep/2025
J&J USD 11.99B 2.37B Dec/2025
Medtronic USD 2.58B 26M Sep/2025
Merck USD 4.15B 102M Sep/2025
Neurocrine Biosciences USD 545.5M 425.6M Dec/2025
Novartis USD 4.56B 49M Sep/2025
Novartis USD 4.56B 49M Sep/2025
Novo Nordisk DKK 19.76B 4.15B Dec/2025
Perrigo USD 469.7M 19.3M Sep/2025
Pfizer USD 5.02B 142M Sep/2025
Phibro Animal Health USD 133.3M 2.7M Dec/2025
Prestige Brands USD 42.95M 1.02M Dec/2025
Regeneron Pharmaceuticals USD 5.83B 4.93B Dec/2025
Roche Holding CHF 5.78B 1.27B Dec/2025
Sanofi EUR 22.93B 927M Dec/2025
Sanofi EUR 22.93B 2.89B Dec/2025
United Therapeutics USD 468M 36M Sep/2025
Zoetis USD 487M 77M Dec/2025